X0306 4 2018-05-17 0001099800 Edwards Lifesciences Corp EW 0001204553 WANG HUIMIN ONE EDWARDS WAY IRVINE CA 92614 1 CVP, Japan & Intercontinental Common Stock 2018-05-17 4 A 0 1325.0000 0.0000 A 84587.6173 D Employee Stock Option (Right to Acquire) 135.8300 2018-05-17 4 A 0 13000.0000 0.0000 A 2018-06-17 2025-05-16 Common Stock 13000.0000 13000.0000 D Performance Rights 2018-05-17 4 A 0 1650.0000 0.0000 A 2021-05-17 2025-05-16 Common Stock 1650.0000 1650.0000 D These restricted stock units were granted on May 17, 2018 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become 50% vested three years after the grant date and 50% vested four years after the grant date. These options were granted on May 17, 2018 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal annual installments. Reflects the target number of shares (the Target Award) covered by restricted stock units granted under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program on May 17, 2018 and scheduled to vest on May 17, 2021. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Award. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Linda J. Park, Attorney-in-Fact 2018-05-21